![(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0…](https://static.cymitquimica.com/products/3D/img/QAC90820.png "Clique para ampliar")
(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione
CAS: 1265908-20-0
Ref. 3D-QAC90820
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
- Ergosta-4,22-diene-3,6-dione, 8,14-epoxy-, (14β,22E)-
- (14β,22E)-8,14-Epoxyergosta-4,22-diene-3,6-dione
(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione is a potent inhibitor of protein kinases that has been shown to have medicinal properties in the treatment of cancer cells and tumors. This compound inhibits the activity of several key proteins involved in the cell cycle and has been found to induce apoptosis in both Chinese hamster ovary cells and human cancer cell lines. Additionally, this compound has demonstrated anticancer activity in animal models and is excreted in urine following administration. The inhibition of protein kinases by (1S,3R,6R,7R,10R,
Propriedades químicas
Consulta técnica sobre: 3D-QAC90820 (1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
